traffic information | weather | web feeds| mobile
Silicon Valley
Part of the Bay Area News Group
  • Site
  • Web Search by YAHOO!
Home
News
Venture Capital
Personal Tech
The Valley
Hot Topics
Phones/Mobile
Social Networks
Green Energy
Security
Companies
Apple
Google
Facebook
Cisco Systems
Intel
Hewlett-Packard
Oracle
Yahoo
eBay
Gilead Sciences
Adobe Systems
Intuit
Netflix
Electronic Arts
Tesla Motors
Twitter
Zynga
SunPower
Solyndra
Kleiner Perkins
People
Steve Jobs
Larry Ellison
Eric Schmidt
Mark Zuckerberg
Carol Bartz
John Doerr
John Chambers
Paul Otellini
Vinod Khosla
Mark Andreessen
Ron Conway
Biz Stone
Elon Musk
Larry Page
Sergey Brin
Ann Livermore
Marissa Mayer
Sheryl Sandberg
T.J. Rodgers
Mark Hurd
columnists
gmsv
Special Reports
Venture Capital Survey
Salary Survey
Silicon Valley 150
Services
RSS Feeds
Mobile Edition
Widgets
Contact Us
Jobs
Advertising
Archives
Go to MercuryNews.com
Silicon Valley 150
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Oracle Unveils New Version of Oracle Health Sciences ClearTrial Plan and Source Enterprise Edition Cloud Service
By: Oracle Corporation via Marketwired News Releases
Posted on February 06, 2013 at 08:00 AM EST
Cloud-Based Clinical Trial Operations Software Delivers Enhanced Planning, Sourcing, and Tracking Capabilities to Support Phase I Trials and Complex Multi-Arm Studies

REDWOOD SHORES, CA -- (Marketwire) -- 02/06/13 -- Oracle (NASDAQ: ORCL)

News Facts

  • Oracle Health Sciences today announced the availability of Oracle Health Sciences ClearTrial Plan and Source Enterprise Edition Cloud Service 5.0, the latest version of the cloud-based clinical trial operations solution that enables life sciences organizations to plan, source and track clinical projects and financial performance via a single, integrated platform.
  • The newest release now provides support for phase I trials, which when combined with existing capabilities, enables organizations to support a broad range of clinical trials -- from initial safety screenings to complex testing and post-approval studies -- in one scalable and flexible solution.
  • Further expanding the breadth and study types that sponsors and contract research organizations (CROs) can create and track, the latest release also provides support for multiple treatment arm studies -- including complex cross over studies, in which different types and sequences of treatment courses are administered to various study groups.
  • Oracle Health Sciences ClearTrial Plan and Source is now delivered via the Oracle Health Sciences Cloud, providing users with improved performance, availability and fault tolerance. In addition, as a cloud-based solution, users will gain immediate access to ClearTrial's enhanced functionality and improved user interface.

Supporting Quote

  • "We remain committed to evolving the breadth and depth of Oracle ClearTrial Plan and Source Cloud Service's capabilities to provide life sciences organizations with the tools they need to conduct and track increasingly complex clinical trials across diverse geographies, outsourcers, therapeutic areas and trial phases," said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. "The new capabilities will allow life sciences organizations to gain a competitive edge in the marketplace while accelerating the process of bringing new therapies to market."

Supporting Resources

  • Oracle in Health Sciences
  • Oracle Health Sciences ClearTrial Plan and Source Cloud Service
  • Chorus Pharma Makes Clinical Trial Budgets More Precise, Less Variable and Enhances Clinical Trial Value Proposition
  • Follow Oracle Health Sciences on Twitter
  • Join the Oracle Health Sciences Community on Facebook
  • Oracle Health Sciences on YouTube

About Oracle
Oracle engineers hardware and software to work together in the cloud and in your data center. For more information about Oracle (NASDAQ: ORCL), visit www.oracle.com.

About Oracle in Industries
Oracle industry solutions leverage the company's best-in-class portfolio of products to address complex business processes relevant to health sciences, helping speed time to market, reduce costs, and gain a competitive edge.

Trademarks
Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Contact Info

Greg Lunsford
Oracle
+1.650.506.6523
Email Contact

Mary Tobin
O'Keeffe & Company
+1.503.658.7396
Email Contact

Related Stocks:
Oracle Corp
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
  • Terms of Use & Privacy Statement
  • Copyright ©
  • About our Ads
  • Find San Jose jobs
  • About MediaNews Group
  • RSS
  • About Bay Area News Group
  • Site Map

Media News Group